StonvexLoading…
StonvexStonvexStonvexCore line items from HCC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $458.59M | $1.31B | $926.05M | $597.47M |
Operating Income | $79.37M | $45.71M | $11.06M | $-9.66M |
Net Income | $72.34M | $57.00M | $34.04M | $-2.56M |
EPS (Diluted) | $1.37 | $1.08 | $0.65 | $-0.05 |
Total Assets | $2.82B | $2.78B | $2.68B | $2.65B |
Total Liabilities | $618.99M | $642.41M | $564.82M | $565.12M |
Cash & Equivalents | $202.60M | $299.96M | $336.28M | $383.25M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 52.80M | 52.57M | 52.57M | 52.57M |